Will intracameral cefuroxime become the new standard in endophthalmitis prevention? [Prophylaxe der postoperativen infektiösen endophthalmitis durch intrakamerale cefuroximgabe – Auf dem weg zum therapiestandard?]

Pleyer U., Geldsetzer K.

2008
Klinische Monatsblatter fur Augenheilkunde

View publication

Therapeutic Area

Other
Categories

Clinical development

Affiliations

Universitäts-Augenklinik, Charité Campus Virchow-Klinik, Firma, Santen GmbH, Germering, Germany, Universitäts-Augenklinik, Charité Campus Virchow-Klinik, Augustenburger Platz 1, 13353 Berlin, Germany

Related Publications

Enhancing Corneal Drug Penetration Using Penetratin for Ophthalmic Suspensions

Morofuji R.; Kudo K.; Honda T.; Kinugasa S.; Matsuo T.; Okabe K.

Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality

Kempen J.H.; Newcomb C.W.; Washington T.L.; Foster C.S.; Sobrin L.; Thorne J.E.; Jabs D.A.; Suhler E.B.; Rosenbaum J.T.; Sen H.N.; Levy-Clarke G.A.; Nussenblatt R.B.; Bhatt N.P.; Lowder C.Y.; Goldstein D.A.; Leiderman Y.I.; Acharya N.R.; Holland G.N.; Read R.W.; Dunn J.P.; Dreger K.A.; Artornsombudh P.; Begum H.A.; Fitzgerald T.D.; Kothari S.; Payal A.R.; Daniel E.; Gangaputra S.S.; Kaçmaz R.O.; Liesegang T.L.; Pujari S.S.; Khachatryan N.; Maghsoudlou A.; Suga H.K.; Pak C.M.; Helzlsouer K.J.; Buchanich J.M.

Exploring Cell-Penetrating Peptides as Penetration Enhancers in Eye Drop Formulations Using a Reconstructed Human Corneal Epithelial Model

Morofuji R.; Enomoto H.; Honda T.; Oyama Y.; Ishida R.; Kudo K.; Okabe K.

View all Other publications